Clinical Trial Update: A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for INCMGA00012 in selected solid tumors, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Melanoma
• Non Small Cell Lung Cancer
• Renal Cell Carcinoma
• Unresectable Melanoma
• Urothelial Cancer

Drugs mentioned

• INCMGA00012

Snippet

Sponsor: Incyte Corporation | Conditions: Metastatic Non-small Cell Lung Cancer, Locally Advanced Urothelial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-05-10